カテゴリ： Transparency Market Research, 世界, 医療/バイオ

モバイル型心臓テレメトリーデバイスの世界市場2023～2031：疾患別

■ 英語タイトル：Mobile Cardiac Telemetry Device Market (Disease Indication: Angina Pectoris, Atherosclerosis, Heart Failure, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

調査会社Transparency Market Research社が発行したリサーチレポート（データ管理コード：TMR23MA131）■ 発行会社/調査会社：Transparency Market Research
■ 商品コード：TMR23MA131
■ 発行日：2023年3月28日
■ 調査対象地域：北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ
■ 産業分野：医療機器
■ ページ数：183
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（納期はお問い合わせください。）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,795 ⇒換算￥880,840見積依頼/購入/質問フォーム
Multi User（5名様閲覧）USD8,795 ⇒換算￥1,336,840見積依頼/購入/質問フォーム
Corporate License（法人閲覧）USD11,795 ⇒換算￥1,792,840見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Transparency Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[モバイル型心臓テレメトリーデバイスの世界市場2023～2031：疾患別]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Transparency Market Research社の本市場調査報告書によると、世界のモバイル型心臓テレメトリーデバイス市場規模が、2023年の942.7百万ドルから2031年には25億ドルまでCAGR 11.6%成長すると予測されています。本書はモバイル型心臓テレメトリーデバイスの世界市場について多角的に調査・分析し、序論、仮定、調査方法、エグゼクティブサマリー、市場概要、新型コロナウイルス感染症分析、用途別（リードベース、パッチベース）分析、疾患別（狭心症、動脈硬化、心不全、その他）分析、エンドユーザー別（病院、専門クリニック、診療所、在宅医療、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況、主要ポイントなどの内容を掲載しています。なお、本書には、BioTelemetry, Inc.、ScottCare、Biotricity, Inc.、Welch Allyn、Applied Cardiac Systems, Inc.、Medicomp, Inc.、Preventice Solutions、Telerhythmics LLC、Zoll Medical Corporation、iRhythm Technologies, Inc.などの企業情報が含まれています。
・序論
・仮定
・調査方法
・エグゼクティブサマリー
・市場概要
・新型コロナウイルス感染症分析
・世界のモバイル型心臓テレメトリーデバイス市場規模：用途別
- リードベースにおける市場規模
- パッチベースにおける市場規模
・世界のモバイル型心臓テレメトリーデバイス市場規模：疾患別
- 狭心症における市場規模
- 動脈硬化における市場規模
- 心不全における市場規模
- その他疾患における市場規模
・世界のモバイル型心臓テレメトリーデバイス市場規模：エンドユーザー別
- 病院における市場規模
- 専門クリニックにおける市場規模
- 診療所における市場規模
- 在宅医療における市場規模
- その他エンドユーザーにおける市場規模
・世界のモバイル型心臓テレメトリーデバイス市場規模：地域別
- 北米のモバイル型心臓テレメトリーデバイス市場規模
- ヨーロッパのモバイル型心臓テレメトリーデバイス市場規模
- アジア太平洋のモバイル型心臓テレメトリーデバイス市場規模
- 中南米のモバイル型心臓テレメトリーデバイス市場規模
- 中東・アフリカのモバイル型心臓テレメトリーデバイス市場規模
・競争状況
・企業情報

Mobile Cardiac Telemetry Device Market – Scope of Report
TMR’s report on the global mobile cardiac telemetry device market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global mobile cardiac telemetry device market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global mobile cardiac telemetry device market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the mobile cardiac telemetry device market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global mobile cardiac telemetry device market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global mobile cardiac telemetry device market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global mobile cardiac telemetry device market.

The report delves into the competitive landscape of the global mobile cardiac telemetry device market. Key players operating in the global mobile cardiac telemetry device market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global mobile cardiac telemetry device market profiled in this report.

Key Questions Answered in Global Mobile Cardiac Telemetry Device Market Report
• What is the sales/revenue generated by mobile cardiac telemetry device across all regions during the forecast period?
• What are the opportunities in the global mobile cardiac telemetry device market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Mobile Cardiac Telemetry Device Market – Research Objectives and Research Approach
The comprehensive report on the global mobile cardiac telemetry device market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global mobile cardiac telemetry device market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global mobile cardiac telemetry device market.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Mobile Cardiac Telemetry Device Market
4. Market Overview
    4.1. Introduction
        4.1.1. Disease Indication Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, 2017–2031
5. Key Insights
    5.1. Technological Advancement
    5.2. Regulatory Analysis
    5.3. Disease Incidence and Prevalence
    5.4. COVID-19 Impact Analysis
6. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, by Application
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast, by Application, 2017 – 2031
        6.3.1. Lead-based
        6.3.2. Patch-based
    6.4. Market Attractiveness Analysis, by Application
7. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, by Disease Indication
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast, by Disease Indication, 2017–2031
        7.3.1. Angina Pectoris
        7.3.2. Atherosclerosis
        7.3.3. Heart Failure
        7.3.4. Others
    7.4. Market Attractiveness, by Disease Indication
8. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, by End-user
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast, by End-user, 2017–2031
        8.3.1. Hospitals
        8.3.2. Specialty Clinics
        8.3.3. Diagnostic Centers
        8.3.4. Home Care Settings
        8.3.5. Others
    8.4. Market Attractiveness Analysis, by End-user
9. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, by Region
10. North America Mobile Cardiac Telemetry Device Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Application, 2017–2031
        10.2.1. Lead-based
        10.2.2. Patch-based
    10.3. Market Value Forecast, by Disease Indication, 2017–2031
        10.3.1. Angina Pectoris
        10.3.2. Atherosclerosis
        10.3.3. Heart Failure
        10.3.4. Others
    10.4. Market Value Forecast, by End-user, 2017–2031
        10.4.1. Hospitals
        10.4.2. Specialty Clinics
        10.4.3. Diagnostic Centers
        10.4.4. Home Care Settings
        10.4.5. Others
    10.5. Market Value Forecast, by Country, 2017–2031
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Application
        10.6.2. By Disease Indication
        10.6.3. By End-user
        10.6.4. By Country
11. Europe Mobile Cardiac Telemetry Device Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Application, 2017–2031
        11.2.1. Lead-based
        11.2.2. Patch-based
    11.3. Market Value Forecast, by Disease Indication, 2017–2031
        11.3.1. Angina Pectoris
        11.3.2. Atherosclerosis
        11.3.3. Heart Failure
        11.3.4. Others
    11.4. Market Value Forecast, by End-user, 2017–2031
        11.4.1. Hospitals
        11.4.2. Specialty Clinics
        11.4.3. Diagnostic Centers
        11.4.4. Home Care Settings
        11.4.5. Others
    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Spain
        11.5.5. Italy
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Application
        11.6.2. By Disease Indication
        11.6.3. By End-user
        11.6.4. By Country/Sub-region
12. Asia Pacific Mobile Cardiac Telemetry Device Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Application, 2017–2031
        12.2.1. Lead-based
        12.2.2. Patch-based
    12.3. Market Value Forecast, by Disease Indication, 2017–2031
        12.3.1. Angina Pectoris
        12.3.2. Atherosclerosis
        12.3.3. Heart Failure
        12.3.4. Others
    12.4. Market Value Forecast, by End-user, 2017–2031
        12.4.1. Hospitals
        12.4.2. Specialty Clinics
        12.4.3. Diagnostic Centers
        12.4.4. Home Care Settings
        12.4.5. Others
    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Application
        12.6.2. By Disease Indication
        12.6.3. By End-user
        12.6.4. By Country/Sub-region
13. Latin America Mobile Cardiac Telemetry Device Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Application, 2017–2031
        13.2.1. Lead-based
        13.2.2. Patch-based
    13.3. Market Value Forecast, by Disease Indication, 2017–2031
        13.3.1. Angina Pectoris
        13.3.2. Atherosclerosis
        13.3.3. Heart Failure
        13.3.4. Others
    13.4. Market Value Forecast, by End-user, 2017–2031
        13.4.1. Hospitals
        13.4.2. Specialty Clinics
        13.4.3. Diagnostic Centers
        13.4.4. Home Care Settings
        13.4.5. Others
    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Market Attractiveness Analysis
        13.6.1. By Application
        13.6.2. By Disease Indication
        13.6.3. By End-user
        13.6.4. By Country/Sub-region
14. Middle East & Africa Mobile Cardiac Telemetry Device Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Application, 2017–2031
        14.2.1. Lead-based
        14.2.2. Patch-based
    14.3. Market Value Forecast, by Disease Indication, 2017–2031
        14.3.1. Angina Pectoris
        14.3.2. Atherosclerosis
        14.3.3. Heart Failure
        14.3.4. Others
    14.4. Market Value Forecast, by End-user, 2017–2031
        14.4.1. Hospitals
        14.4.2. Specialty Clinics
        14.4.3. Diagnostic Centers
        14.4.4. Home Care Settings
        14.4.5. Others
    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.5.1. Brazil
        14.5.2. Mexico
        14.5.3. Rest of Latin America
    14.6. Market Attractiveness Analysis
        14.6.1. By Application
        14.6.2. By Disease Indication
        14.6.3. By End-user
        14.6.4. By Country/Sub-region
15. Competition Landscape
    15.1. Market Player – Competition Matrix (by tier and size of companies)
    15.2. Market Share Analysis, by Company, 2022
    15.3. Company Profiles
        15.3.1. BioTelemetry, Inc.
            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.1.2. Test Application Portfolio
            15.3.1.3. Financial Overview
            15.3.1.4. SWOT Analysis
            15.3.1.5. Strategic Overview
        15.3.2. ScottCare
            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.2.2. Test Application Portfolio
            15.3.2.3. Financial Overview
            15.3.2.4. SWOT Analysis
            15.3.2.5. Strategic Overview
        15.3.3. Biotricity Inc.
            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.3.2. Test Application Portfolio
            15.3.3.3. Financial Overview
            15.3.3.4. SWOT Analysis
            15.3.3.5. Strategic Overview
        15.3.4. Welch Allyn
            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.4.2. Test Application Portfolio
            15.3.4.3. Financial Overview
            15.3.4.4. SWOT Analysis
            15.3.4.5. Strategic Overview
        15.3.5. Applied Cardiac Systems, Inc.
            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.5.2. Test Application Portfolio
            15.3.5.3. Financial Overview
            15.3.5.4. SWOT Analysis
            15.3.5.5. Strategic Overview
        15.3.6. Medicomp, Inc.
            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.6.2. Test Application Portfolio
            15.3.6.3. Financial Overview
            15.3.6.4. SWOT Analysis
            15.3.6.5. Strategic Overview
        15.3.7. Preventice Solutions
            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.7.2. Test Application Portfolio
            15.3.7.3. Financial Overview
            15.3.7.4. SWOT Analysis
            15.3.7.5. Strategic Overview
        15.3.8. Telerhythmics LLC
            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.8.2. Test Application Portfolio
            15.3.8.3. Financial Overview
            15.3.8.4. SWOT Analysis
            15.3.8.5. Strategic Overview
        15.3.9. Zoll Medical Corporation
            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.9.2. Test Application Portfolio
            15.3.9.3. Financial Overview
            15.3.9.4. SWOT Analysis
            15.3.9.5. Strategic Overview
        15.3.10. iRhythm Technologies, Inc.
            15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.10.2. Test Application Portfolio
            15.3.10.3. Financial Overview
            15.3.10.4. SWOT Analysis
            15.3.10.5. Strategic Overview

List of Tables

Table 1: Global overview of Surgical Mobile Cardiac Telemetry Device

Table 2: Regional overview of Surgical Mobile Cardiac Telemetry Device

Table 4: North America Overview of Surgical Mobile Cardiac Telemetry Device

Table 4: Asia Pacific overview of Surgical Mobile Cardiac Telemetry Device

Table 5: Global Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Application, 2023–2031

Table 6: Global Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Disease Indication, 2023–2031

Table 7: Global Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by End-user, 2023–2031

Table 8: Global Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Region, 2023–2031

Table 9: North America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Country, 2023–2031

Table 10: North America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Application, 2023–2031

Table 11: North America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Disease Indication, 2023–2031

Table 12: North America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by End-user, 2023–2031

Table 13: Europe Surgical Mobile Cardiac Telemetry Device Revenue (US$ Mn) Forecast, by Country/Sub-region, 2023–2031

Table 14: Europe Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Application, 2023–2031

Table 15: Europe Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Disease Indication, 2023–2031

Table 16: Europe Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by End-user, 2023–2031

Table 17: Asia Pacific Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2031

Table 18: Asia Pacific Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Application, 2023–2031

Table 19: Asia Pacific Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Disease Indication, 2023–2031

Table 20: Asia Pacific Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by End-user, 2023–2031

Table 21: Latin America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2031

Table 22: Latin America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Application, 2023–2031

Table 23: Latin America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Disease Indication, 2023–2031

Table 24: Latin America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by End-user, 2023–2031

Table 25: Middle East & Africa Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2031

Table 26: Middle East & Africa Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Application, 2023–2031

Table 27: Middle East & Africa Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Disease Indication, 2023–2031

Table 28: Middle East & Africa Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by End-user, 2023–2031

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 低侵襲手術の世界市場2023-2031：産業分析、規模、シェア、成長、動向、予測
  • 経カテーテル心臓弁置換及び修復術の世界市場2023～2031：処置別
  • 色素沈着症治療の世界市場2023～2031：治療法別
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(TMR23MA131 )"モバイル型心臓テレメトリーデバイスの世界市場2023～2031：疾患別" (英文：Mobile Cardiac Telemetry Device Market (Disease Indication: Angina Pectoris, Atherosclerosis, Heart Failure, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031)はTransparency Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。